本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Humacyte, Inc.

1.48
-0.0200-1.33%
盘后1.500.0200+1.35%19:32 EDT
成交量:204.61万
成交额:302.70万
市值:2.34亿
市盈率:-3.36
高:1.53
开:1.51
低:1.45
收:1.50
52周最高:6.77
52周最低:1.15
股本:1.58亿
流通股本:1.25亿
量比:0.78
换手率:1.63%
股息:- -
股息率:- -
每股收益(TTM):-0.4403
每股收益(LYR):-1.2551
净资产收益率:-249.75%
总资产收益率:-50.18%
市净率:57.85
市盈率(LYR):-1.18

数据加载中...

2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/09

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report